Recent Announcement: Shenzhen Tobacco Monopoly Bureau's Responsibility List

Sep.19.2023
Recent Announcement: Shenzhen Tobacco Monopoly Bureau's Responsibility List
Recently, the Shenzhen Tobacco Monopoly Bureau released a list of rights and responsibilities. (Original Article: Shenzhen Tobacco Monopoly Bureau List of Rights and Responsibilities)

Recently, the Shenzhen Tobacco Monopoly Bureau released its list of powers and responsibilities. (Click to view the original article: List of Powers and Responsibilities of the Shenzhen Tobacco Monopoly Bureau)

 

The following is the full text:

 

Legal Basis (including national laws, regulations, rules, administrative normative documents, etc.):

 

Law of the People's Republic of China on Tobacco Monopoly" (Presidential Decree of the People's Republic of China No. 26, Revised on April 24, 2015)

 

The Implementation Regulations of the Tobacco Monopoly Law of the People's Republic of China (State Council Decree No. 750 of the People's Republic of China, revised on November 10, 2021)

 

The Administrative Coercion Law of the People's Republic of China (Presidential Decree No. 49 of the People's Republic of China, amended on June 30, 2011)

 

Administrative Reconsideration Law of the People's Republic of China" (Presidential Decree No. 16 of the People's Republic of China, revised on September 1, 2017)

 

Administrative Reconsideration Law Implementation Regulations of the People's Republic of China (State Council Decree No. 499, published on May 29, 2007)

 

6. "Administrative Penalties Procedures for Tobacco Monopoly" (Order No. 61 of the Ministry of Industry and Information Technology, January 21, 2010, amended on May 16, 2023).

 

Regulations on the Management of Tobacco Monopoly License (Ministry of Industry and Information Technology of the People's Republic of China Decree No. 36, revised on May 26, 2016)

 

Regulations on the Administration of Tobacco Monopoly Licenses" (Order No. 37 of the Ministry of Industry and Information Technology of the People's Republic of China, revised on May 26, 2016)

 

Regulations on the Management of E-Cigarettes" (Announcement No. 1 of 2022 by the State Tobacco Monopoly Administration)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao argues that nicotine pouches are no longer a niche alternative, but a force quietly reshaping the future of tobacco retail. For distributors and retailers, the real risk is not missing a trend—it is moving too late, after regulation tightens, shelf space hardens and the market begins to choose its winners.
Mar.31 by Alan Zhao | 2Firsts Perspectives
Illinois HB 4652 Targets Discarded Vapes, Would Require Manufacturer-Funded Disposal Programs
Illinois HB 4652 Targets Discarded Vapes, Would Require Manufacturer-Funded Disposal Programs
Illinois House Bill 4652 proposes e-cigarette companies establish and fund safe disposal programs to combat environmental risks.
Mar.09 by 2FIRSTS.ai
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
On March 27, 2026, PLONQ officially opened its upgraded Shenzhen office, reinforcing its long-term commitment to China and marking a new phase of growth. As a leading vape brand in Russia, PLONQ is expanding into new product categories while strengthening R&D, engineering collaboration, and partnerships with Chinese companies. The Shenzhen office will accelerate product development, enhance cooperation with technology and manufacturing partners, and support future growth initiatives.
Apr.01
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents
China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents
China Tobacco Hubei Industrial Co., Ltd applies for patents on new nicotine pouch technology with gas release feature.
Mar.04 by 2FIRSTS.ai